EX-32.1 5 tmb-20210630xex32d1.htm EX-32.1

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

​

In connection with the Quarterly Report on Form 10-Q of Immunome, Inc. (the “Company”) for the fiscal quarter ended June 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

| (1) | the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

| (2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

​

​ | ​ | ​
Date: August 16, 2021 | By: | /s/ Purnanand D. Sarma
​ | Name: | Purnanand D. Sarma, Ph.D.
​ | Title: | President and Chief Executive Officer (Principal Executive Officer)

​